Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-052010
Filing Date
2021-08-17
Accepted
2021-08-17 18:11:37
Documents
1
Period of Report
2021-08-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4130
  Complete submission text file 0001209191-21-052010.txt   5734
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Issuer) CIK: 0001061027 (see all company filings)

EIN.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REVOLUTION MEDICINES, INC. 700 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address
Borellini Flavia (Reporting) CIK: 0001867426 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51531 | Film No.: 211184416